0.380 (0.0%)
Last updated: 16:59
Fundamental   2.1  
Technical   4.2  
Total Score   6.3  

 ST Sell- 
Hovid chart by TradingView

iSaham Fundamental Trend - HOVID

FCON: 0.44 | LTS: 4.0

Financial Ratios - HOVID

Trailing PE (Sector Median: 16.6) 33.2
EV/EBITDA (Sector Median: 10.6) 14.0
PEG -9.76
Sharpe Ratio (3-yrs) -0.17
Altman Z 2.6
Beaver -0.028
Current Ratio 1.75
Debt-Equity (DE) Ratio 0.64
FCF Yield -5.39 %
Revenue QoQ 2.41 %
Profit QoQ 23.33 %
Profit YoY 373.46 %
NTA QoQ 8.54 %
Profit Margin (Sector Median: 5.9) 4.37 %
ROE 4.27 %
ROIC 3.31 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

Support & Resistance

ATR Trailing Stop: 0.375

Last Price
Price 0.36 0.37 0.375 0.38 0.38 0.38 0.385
Volume (M) 414.3 236.4 234.4 300.3 300.3 126.5

Gann Support (EP/CL): 0.37/0.34 | Resistance (TP): 0.4/0.43
iGann Support (EP/CL): 0.35/0.32 | Resistance (TP): 0.4/0.43

*Highlighted column shows significant volume at the support or resistance area.

Technical Trend

Moving Average Trend
Volume Trend

Trading Signalsbeta - HOVID

Based on iSaham Screeners

Moving Average (Short Term) HOLD
Moving Average (Mid Term) HOLD
Moving Average (Long Term) BUY
Ichimoku Kumo HOLD
Bollinger Band -
Stochastic SELL
Heikin-Ashi HOLD
MACD BUY (Above 0)
Solid MA Trend BUY
Sector Trend (Long Term) SELL
Sector Trend (Short Term) SELL
Institutional Holdings -
Beat The Insti -
Magic Formula -
Better Than ASB -
52-Week High -
T+ -
Candlestick -
Chart Pattern -

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Fair Value

iSaham Fair Value: 0.1

Discounted Cash Flow (DCF)5.0% Growth 0.1
Discounted Cash Flow (DCF)-3.4% Growth 0.065
Relative Valuation 0.19
Graham Formula 0.085
Graham Number 0.26
Net Tangible Asset MA 0.26

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 65.49
Expected Revenue (M) 1498.55
Expected Growth (%) 31.0


Market Cap: 313 M.

Number of Shares: 826 M.

Float: 12.12%.

Stock highly correlated with

FPI (78%)

SPB (71%)

MERGE (64%)

GCB (63%)

Hovid Berhad manufactures and sells pharmaceutical and herbal products in Malaysia. It offers ethical pharmaceutical products, including antibiotics, anti diabetics, anti hypertensives, anti malarial, and anti inflammatory analgesics; dietary supplements, such as vitamins and minerals, antioxidant formulations, and herbal supplements; and consumer products, including cosmetics and toiletries, herbal teas, and disinfectants. The company, through its subsidiaries, is also engaged in the extraction and processing of nutrients from palm oil for the purpose of manufacturing and producing pharmaceutical, phytonutrient, and oleochemicals/biodiesel products; wholesale and distribution of medical supplies, pharmaceutical products, consumer products, embrocation oil, herbal tea, and Chinese patented medicines; and marketing of pharmaceutical, phytonutrient, and oleochemical products. In addition, it owns and manages a chain of concept stores selling over-the-counter health food products, consumer products, supplements, and herbal products. Hovid also operates in Africa, North and South America, Europe, and Pacific Island. The company, formerly known as Ho Yan Hor, was founded in 1945. Hovid Berhad is based in Ipoh, Malaysia.

Code: 7213

Website: http://www.hovid.com/

Related Links: Bursa | Analyst Report | Annual Report | Announcement

Top Shareholdings

Shareholder Value (M)
Fajar Astorio Sdn. Bhd. 142.95
Ho Sue San @ David Ho Sue San 105.19
Lim Chee Sing 2.17
Teo Kwee Hock 1.34
Pua Soon 1.25
Gan Tee Jin 1.03
Cheng Teck Loong 0.99
Teo Siew Lai 0.82
Md. Shah bin Abu Hasan 0.7
Wong Tack Peng 0.67
Cheng Yee Ven 0.67
Chong Chee Hui 0.63
Shin Lee Yeunch @ Chin Lee Yeuk 0.56
Chin Yoke Shu 0.55
Choo Fui Ann 0.5
Ng Chai Hock 0.42
Lee Lai Hong 0.41
Tee Chee Chiang 0.4
Credit Suisse 0.38
Wong Chong Leong 0.38
Seah Hooi Cheng 0.38
Pacific Pearl Fund 0.38
Ng Nguk Foong 0.35
Chee Sai Mun 0.34
Tang Kok Heng 0.3